We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 - REVENUE +12.0%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +9.5% Consolidated net revenue of € 1,743.1 million in the...
RECORDATI ANNOUNCES AGREEMENT TO ACQUIRE THE GLOBAL RIGHTS TO ENJAYMO®, STRENGTHENING ITS RARE DISEASES FRANCHISE Milan, 4th October 2024 – Recordati today announces an agreement with Sanofi...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.2 | 2.19378427788 | 54.7 | 56 | 54.2 | 178 | 54.95121495 | DE |
4 | 5.1 | 10.0393700787 | 50.8 | 56 | 50.55 | 376 | 53.39714032 | DE |
12 | 3.85 | 7.3967339097 | 52.05 | 56 | 49.6 | 209 | 52.29660066 | DE |
26 | 4.35 | 8.43840931135 | 51.55 | 56 | 48.56 | 185 | 51.86494353 | DE |
52 | 5.96 | 11.9343211854 | 49.94 | 56 | 47.44 | 210 | 50.91410209 | DE |
156 | 9.95 | 21.6539717084 | 45.95 | 56 | 43.41 | 210 | 49.66804355 | DE |
260 | 9.95 | 21.6539717084 | 45.95 | 56 | 43.41 | 210 | 49.66804355 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions